BIOTRONIK won FDA approval for its Orsiro drug-eluting coronary stent, an ultrathin device that’s already been approved in Europe for eight years and has been implanted in more than a million patients worldwide.
The Orsiro is a cobalt chromium metal stent that releases sirolimus, which helps to prevent restenosis. This is performed by BIOTRO (Read more...)